IQVIA’s Marie Flanagan explains why governance must be built into AI design from the start.

How Boehringer Ingelheim is buttressing its US business

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&amp;D and device development. Available every Friday morning.&nbsp;